NFKB1 and inflammatory bowel disease: In conclusion, DW18134 exhibited potential for attenuating macrophage infiltration, restoring intestinal barrier integrity, modulating the NF-κB pathway through the IRAK4 targeting mechanism, and suppressing inflammatory factor secretion to combat IBD.